Cargando…
Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling
Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughput studies. Signatures, composed of features such as mRNAs, miRNAs, SNPs or other molecular variables, are often non-overlapping, even though they have been identified from similar experiments consider...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190101/ https://www.ncbi.nlm.nih.gov/pubmed/25295525 http://dx.doi.org/10.1371/journal.pone.0108818 |
_version_ | 1782338459615100928 |
---|---|
author | Lee, Sangkyun Rahnenführer, Jörg Lang, Michel De Preter, Katleen Mestdagh, Pieter Koster, Jan Versteeg, Rogier Stallings, Raymond L. Varesio, Luigi Asgharzadeh, Shahab Schulte, Johannes H. Fielitz, Kathrin Schwermer, Melanie Morik, Katharina Schramm, Alexander |
author_facet | Lee, Sangkyun Rahnenführer, Jörg Lang, Michel De Preter, Katleen Mestdagh, Pieter Koster, Jan Versteeg, Rogier Stallings, Raymond L. Varesio, Luigi Asgharzadeh, Shahab Schulte, Johannes H. Fielitz, Kathrin Schwermer, Melanie Morik, Katharina Schramm, Alexander |
author_sort | Lee, Sangkyun |
collection | PubMed |
description | Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughput studies. Signatures, composed of features such as mRNAs, miRNAs, SNPs or other molecular variables, are often non-overlapping, even though they have been identified from similar experiments considering samples with the same type of disease. The lack of a consensus is mostly due to the fact that sample sizes are far smaller than the numbers of candidate features to be considered, and therefore signature selection suffers from large variation. We propose a robust signature selection method that enhances the selection stability of penalized regression algorithms for predicting survival risk. Our method is based on an aggregation of multiple, possibly unstable, signatures obtained with the preconditioned lasso algorithm applied to random (internal) subsamples of a given cohort data, where the aggregated signature is shrunken by a simple thresholding strategy. The resulting method, RS-PL, is conceptually simple and easy to apply, relying on parameters automatically tuned by cross validation. Robust signature selection using RS-PL operates within an (external) subsampling framework to estimate the selection probabilities of features in multiple trials of RS-PL. These probabilities are used for identifying reliable features to be included in a signature. Our method was evaluated on microarray data sets from neuroblastoma, lung adenocarcinoma, and breast cancer patients, extracting robust and relevant signatures for predicting survival risk. Signatures obtained by our method achieved high prediction performance and robustness, consistently over the three data sets. Genes with high selection probability in our robust signatures have been reported as cancer-relevant. The ordering of predictor coefficients associated with signatures was well-preserved across multiple trials of RS-PL, demonstrating the capability of our method for identifying a transferable consensus signature. The software is available as an R package rsig at CRAN (http://cran.r-project.org). |
format | Online Article Text |
id | pubmed-4190101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41901012014-10-10 Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling Lee, Sangkyun Rahnenführer, Jörg Lang, Michel De Preter, Katleen Mestdagh, Pieter Koster, Jan Versteeg, Rogier Stallings, Raymond L. Varesio, Luigi Asgharzadeh, Shahab Schulte, Johannes H. Fielitz, Kathrin Schwermer, Melanie Morik, Katharina Schramm, Alexander PLoS One Research Article Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughput studies. Signatures, composed of features such as mRNAs, miRNAs, SNPs or other molecular variables, are often non-overlapping, even though they have been identified from similar experiments considering samples with the same type of disease. The lack of a consensus is mostly due to the fact that sample sizes are far smaller than the numbers of candidate features to be considered, and therefore signature selection suffers from large variation. We propose a robust signature selection method that enhances the selection stability of penalized regression algorithms for predicting survival risk. Our method is based on an aggregation of multiple, possibly unstable, signatures obtained with the preconditioned lasso algorithm applied to random (internal) subsamples of a given cohort data, where the aggregated signature is shrunken by a simple thresholding strategy. The resulting method, RS-PL, is conceptually simple and easy to apply, relying on parameters automatically tuned by cross validation. Robust signature selection using RS-PL operates within an (external) subsampling framework to estimate the selection probabilities of features in multiple trials of RS-PL. These probabilities are used for identifying reliable features to be included in a signature. Our method was evaluated on microarray data sets from neuroblastoma, lung adenocarcinoma, and breast cancer patients, extracting robust and relevant signatures for predicting survival risk. Signatures obtained by our method achieved high prediction performance and robustness, consistently over the three data sets. Genes with high selection probability in our robust signatures have been reported as cancer-relevant. The ordering of predictor coefficients associated with signatures was well-preserved across multiple trials of RS-PL, demonstrating the capability of our method for identifying a transferable consensus signature. The software is available as an R package rsig at CRAN (http://cran.r-project.org). Public Library of Science 2014-10-08 /pmc/articles/PMC4190101/ /pubmed/25295525 http://dx.doi.org/10.1371/journal.pone.0108818 Text en © 2014 Lee et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Lee, Sangkyun Rahnenführer, Jörg Lang, Michel De Preter, Katleen Mestdagh, Pieter Koster, Jan Versteeg, Rogier Stallings, Raymond L. Varesio, Luigi Asgharzadeh, Shahab Schulte, Johannes H. Fielitz, Kathrin Schwermer, Melanie Morik, Katharina Schramm, Alexander Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling |
title | Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling |
title_full | Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling |
title_fullStr | Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling |
title_full_unstemmed | Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling |
title_short | Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling |
title_sort | robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190101/ https://www.ncbi.nlm.nih.gov/pubmed/25295525 http://dx.doi.org/10.1371/journal.pone.0108818 |
work_keys_str_mv | AT leesangkyun robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT rahnenfuhrerjorg robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT langmichel robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT depreterkatleen robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT mestdaghpieter robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT kosterjan robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT versteegrogier robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT stallingsraymondl robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT varesioluigi robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT asgharzadehshahab robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT schultejohannesh robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT fielitzkathrin robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT schwermermelanie robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT morikkatharina robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling AT schrammalexander robustselectionofcancersurvivalsignaturesfromhighthroughputgenomicdatausingtwofoldsubsampling |